← FDA ENFORCEMENT
Z-1927-2026Class II

Foundation Medicine, Inc.

Recalling firm
Foundation Medicine, Inc.
Product type
Device
Status
Ongoing
Report date
2026-04-29
Distribution
US Nationwide distribution in the states of Massachusetts and North Carolina.
Firm state
MA
Product quantity
163 units
Initiated by
Voluntary: Firm initiated
Reason for recall

Possible increase in phasing, potentially resulting in false-positive BARD1 splice site indel artifact variants

Product description

Sequencing Agent SEQ0067, component of FoundationOne CDx (F1CDx)

Code / lot info

Model Number: SEQ0067. Lot Numbers: 24346, 24386, 24488.

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.